Skip to Main Content

Print | Bookmark | Email | Font Size: + |

August 22, 2023

CGS J15 Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers: L36690/A56696

Join the CGS J15 Part A and B Chief Medical Officer, Meredith Loveless, MD. FACOG on Friday,  September 22, 2023 from 10:00AM to 11:00AM Eastern Time discuss the recent changes on the CGS Local Coverage Determination (LCD) L36690 Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers and A56696 Billing and Coding: Skin Substitutes Grafts/Cellular Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers. During this call you will be able to identify the recent guidelines that were implemented on August 3, 2023 and have your pre submitted questions addressed.

Who should attend, physicians, practitioners, coders, and billing staff.

Registration is required at  https://events.teams.microsoft.com/event/59e9dffb-4af9-4249-b59a-d73e8385f265@d560165e-85d7-436f-a978-c588cf12ebe1External Website

Once you register to attend this event you will see the items that will be discussed during this hour event.  We ask that you take a few minutes to review and submit your questions prior to the event. Pre-submitted questions can be submitted to J15_PARTB_EDUCATION@cgsadmin.com

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved